Literature DB >> 15670709

The COT1 homologue CPCOT1 regulates polar growth and branching and is essential for pathogenicity in Claviceps purpurea.

Jan Scheffer1, Carmit Ziv, Oded Yarden, Paul Tudzynski.   

Abstract

Claviceps purpurea, the ergot fungus, is a common grass pathogen attacking exclusively young ovaries. Its pathogenic development involves an early phase of directed growth (with strictly suppressed branching) towards the floral vascular tissue. Since Ser/Thr protein kinases of the NDR family have been shown to be involved in polar growth and branching in fungi, we have analyzed a C. purpurea homologue of the Neurospora crassa cot-1 gene, cpcot1. It encodes a functional homologue of COT1 since it can fully complement the N. crassa cot-1 mutant phenotype. Delta cpcot1 mutants are significantly impaired in vegetative growth properties: they are characterized by hyperbranching, reduced growth rate, and decreased conidiation. Infection studies on rye plants and isolated ovaries show that the delta cpcot1 mutants are apathogenic; microscopical analyses indicate a very early block, probably in penetration. Thus CPCOT1 is not only involved in polarity and branching and hence oriented growth in the host tissue as expected, but it is essential for the initiation of infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15670709     DOI: 10.1016/j.fgb.2004.10.005

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  11 in total

1.  Regulation of Neurospora crassa cell wall remodeling via the cot-1 pathway is mediated by gul-1.

Authors:  Inbal Herold; Oded Yarden
Journal:  Curr Genet       Date:  2016-06-30       Impact factor: 3.886

2.  A CDC42 homologue in Claviceps purpurea is involved in vegetative differentiation and is essential for pathogenicity.

Authors:  Jan Scheffer; Changbin Chen; Patrick Heidrich; Martin B Dickman; Paul Tudzynski
Journal:  Eukaryot Cell       Date:  2005-07

3.  Bidirectional-genetics platform, a dual-purpose mutagenesis strategy for filamentous fungi.

Authors:  Jaejin Park; Yong-Hwan Lee
Journal:  Eukaryot Cell       Date:  2013-09-20

4.  Depletion of Aspergillus nidulans cotA causes a severe polarity defect which is not suppressed by the nuclear migration mutation nudA2.

Authors:  Sarah Anne Johns; Abigail Claire Leeder; Mehran Safaie; Geoffrey Turner
Journal:  Mol Genet Genomics       Date:  2006-02-28       Impact factor: 3.291

5.  Space-time decoupling in the branching process in the mutant étoile of the filamentous brown alga Ectocarpus siliculosus.

Authors:  Zofia Nehr; Bernard Billoud; Aude Le Bail; Bénédicte Charrier
Journal:  Plant Signal Behav       Date:  2011-12

6.  Two NDR kinase-MOB complexes function as distinct modules during septum formation and tip extension in Neurospora crassa.

Authors:  Sabine Maerz; Anne Dettmann; Carmit Ziv; Yi Liu; Oliver Valerius; Oded Yarden; Stephan Seiler
Journal:  Mol Microbiol       Date:  2009-09-28       Impact factor: 3.501

7.  The N-terminal region of the Neurospora NDR kinase COT1 regulates morphology via its interactions with MOB2A/B.

Authors:  Carmit Ziv; Daria Feldman; Liran Aharoni-Kats; She Chen; Yi Liu; Oded Yarden
Journal:  Mol Microbiol       Date:  2013-09-08       Impact factor: 3.501

8.  In vitro analyses of mild heat stress in combination with antifungal agents against Aspergillus fumigatus biofilm.

Authors:  Rong Zeng; Min Li; Qing Chen; Le Wang; Ping Zhan; Chong Wang; Guixia Lv; Yongnian Shen; Weida Liu
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

9.  DNA mutations mediate microevolution between host-adapted forms of the pathogenic fungus Cryptococcus neoformans.

Authors:  Denise A Magditch; Tong-Bao Liu; Chaoyang Xue; Alexander Idnurm
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

Review 10.  Advances in targeting and heterologous expression of genes involved in the synthesis of fungal secondary metabolites.

Authors:  Yun-Ming Qiao; Rui-Lin Yu; Ping Zhu
Journal:  RSC Adv       Date:  2019-10-30       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.